Key findings: A March 2025 analytical report by supplement company Niagen Bioscience on 21 top-selling NAD supplements on Amazon revealed significant discrepancies between product claims and actual content: Only 24% met claims: Only 5 hard capsules contained NAD levels matching their labeled amounts
At trial completion, the primary outcome occurred in 108 patients (6.6%) in the semaglutide group versus 146 patients (8.9%) in the placebo group (hazard ratio [HR]: 0.74
In addition to the drug itself, the needles, pen labels, carton and accompanying health care information are also counterfeit, the agency said
1 Professor Vlado Perkovic further states, These findings offer great promise in reshaping treatment strategies for individuals at high risk of diabetes-related complications, offering a new avenue for kidney and cardiovascular protection. The FLOW trial was overseen by an academic-led Steering Committee, in partnership with the study sponsor, Novo Nordisk, which also managed trial operations
A., Sperduto, J
As more clients share their positive experiences, weve expanded our branches to meet growing demand